Thelansis

  Recurrent Clostridioides difficile infection (rCDI) is a common complication of Clostridioides difficile infection (CDI). It occurs when a patient has two or more episodes of CDI within 8 weeks of completing treatment for the first episode. rCDI can be difficult to treat and is associated with increased morbidity, mortality, and healthcare costs. The exact cause of rCDI is not fully understood, but it is thought to be due to several factors, including: Ineffective antibiotic treatment: Antibiotics can kill good gut bacteria, allowing C. difficile to grow and cause infection. Persistent C. difficile spores: C. difficile can form spores resistant to antibiotics. These spores can survive in the gut and cause infection even after antibiotic treatment. Immunocompromised state: People with a weakened immune system are more likely to develop rCDI. Other medical conditions: People with certain medical conditions, such as inflammatory bowel disease (IBD) ...